Literature DB >> 30475670

PHOENIX-GC Trial: Underpowered for Significant Results?

Ziyu Li1, Kan Xue1, Xiangji Ying1, Jiafu Ji1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30475670     DOI： 10.1200/JCO.18.00364

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.

Authors:  Daryl K A Chia; Raghav Sundar; Guowei Kim; Jia Jun Ang; Jeffrey H Y Lum; Min En Nga; Giap Hean Goh; Ju Ee Seet; Cheng Ean Chee; Hon Lyn Tan; Jingshan Ho; Natalie Y L Ngoi; Matilda X W Lee; Vaishnavi Muthu; Gloria H J Chan; Angela S L Pang; Yvonne L E Ang; Joan R E Choo; Joline S J Lim; Jun Liang Teh; Aung Lwin; Yuen Soon; Asim Shabbir; Jimmy B Y So; Wei Peng Yong
Journal:  Ann Surg Oncol       Date:  2022-09-07       Impact factor: 4.339

Review 2.  Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer.

Authors:  Daryl K A Chia; Jimmy B Y So
Journal:  J Gastric Cancer       Date:  2020-04-10       Impact factor: 3.720
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.